Neurosense Therapeutics Ltd (NRSN) — Financial Flexibility Index
Neurosense Therapeutics Ltd (NRSN) has a Financial Flexibility Index of 0.00x as of June 2025. Free cash flow of $-2.00K (operating CF $-2.00K minus capex $0.00) represents 0% of total liabilities ($2.20 Million). Also explore NRSN net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Neurosense Therapeutics Ltd Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Neurosense Therapeutics Ltd across 6 annual periods. Check Neurosense Therapeutics Ltd (NRSN) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Neurosense Therapeutics Ltd (2019–2024)
Year-by-year free cash flow to debt coverage for Neurosense Therapeutics Ltd. For the full company profile including market capitalisation, see market cap of Neurosense Therapeutics Ltd.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.09x | $-10.13 Million | $-10.13 Million | $1.99 Million | ▼ -202.1% |
| 2023 | -1.68x | $-8.32 Million | $-8.35 Million | $4.94 Million | ▲ +53.2% |
| 2022 | -3.59x | $-7.52 Million | $-7.59 Million | $2.09 Million | ▼ -472.7% |
| 2021 | -0.63x | $-1.52 Million | $-1.54 Million | $2.42 Million | ▲ +89.0% |
| 2020 | -5.72x | $-686.00K | $-695.00K | $120.00K | ▲ +63.2% |
| 2019 | -15.54x | $-575.00K | $-582.00K | $37.00K | — |